Trade Summary

4 days ago, Garcia Marino, serving as CEO AND PRESIDENT at Dianthus Therapeutics, Inc. /DE/ (DNTH), sold 166,000 shares at $108.11 per share, for a total transaction value of $17,945,451.37. Following this transaction, Garcia Marino now holds 65,292 shares of DNTH.

This sale represents a 71.77% decrease in Garcia Marino's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Friday, August 7, 2026 and publicly disclosed via SEC Form 4 filing on Friday, August 7, 2026 at 6:30 PM ET, meaning the disclosure happened on the same day as the trade.

Dianthus Therapeutics, Inc. /DE/ operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.